Stock Scorecard



Stock Summary for ProPhase Labs Inc (PRPH) - $0.42 as of 7/11/2025 8:49:46 PM EST

Total Score

6 out of 30

Safety Score

13 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PRPH

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PRPH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PRPH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PRPH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PRPH (13 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PRPH

Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket - Blue Gold ( NASDAQ:BGL ) , BioSig Technologies ( NASDAQ:BSGM ) 7/8/2025 10:15:00 AM
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule 6/26/2025 11:30:00 AM
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer 6/17/2025 11:30:00 AM
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform 6/6/2025 11:00:00 AM
Vivos Therapeutics, Inc. ( VVOS ) Reports Q1 Loss, Lags Revenue Estimates 5/15/2025 10:00:00 PM
ARS Pharmaceuticals, Inc. ( SPRY ) Reports Q1 Loss, Lags Revenue Estimates 5/14/2025 12:15:00 PM
Inotiv, Inc. ( NOTV ) Reports Q2 Loss, Tops Revenue Estimates 5/7/2025 10:45:00 PM
BioCryst Pharmaceuticals ( BCRX ) Reports Break-Even Earnings for Q1 5/5/2025 12:20:00 PM
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 3/27/2025 12:27:00 PM
Durect ( DRRX ) Reports Q4 Loss, Lags Revenue Estimates 3/26/2025 9:20:00 PM

Financial Details for PRPH

Company Overview

Ticker PRPH
Company Name ProPhase Labs Inc
Country USA
Description ProPhase Labs, Inc. is engaged in the research, development, manufacture, distribution, marketing, and sale of consumer health products and over-the-counter (OTC) dietary supplements in the United States. The company is headquartered in Garden City, New York.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 3/31/2025
Next Earnings Date 8/7/2025

Stock Price History

Last Day Price 0.42
Price 4 Years Ago 6.61
Last Day Price Updated 7/11/2025 8:49:46 PM EST
Last Day Volume 350,276
Average Daily Volume 2,940,423
52-Week High 3.45
52-Week Low 0.22
Last Price to 52 Week Low 90.91%

Valuation Measures

Trailing PE N/A
Industry PE 22.40
Sector PE 41.70
5-Year Average PE 1.94
Free Cash Flow Ratio 0.00
Industry Free Cash Flow Ratio 18.02
Sector Free Cash Flow Ratio 33.25
Current Ratio Most Recent Quarter 1.03
Total Cash Per Share 0.00
Book Value Per Share Most Recent Quarter 0.36
Price to Book Ratio 1.17
Industry Price to Book Ratio 34.60
Sector Price to Book Ratio 31.09
Price to Sales Ratio Twelve Trailing Months 3.06
Industry Price to Sales Ratio Twelve Trailing Months 120.05
Sector Price to Sales Ratio Twelve Trailing Months 35.30
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 41,541,200
Market Capitalization 17,447,304
Institutional Ownership 12.14%

Dividends

Ex-Dividend Date 5/24/2022
Previous Dividend Amount 0.0000
Current Dividend Amount 0.3000
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 3
3-Year Average Dividend Yield 5.21%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 100.00%
3-Year Dividend Growth Rate Percentage 9.54%
5-Year Dividend Growth Rate Percentage -15.66%
All-Time Dividend Growth Rate Percentage -15.66%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -95.20%
Annual Earnings Growth -217.98%
Reported EPS 12 Trailing Months -2.23
Reported EPS Past Year -0.13
Reported EPS Prior Year -2.34
Net Income Twelve Trailing Months -43,133,000
Net Income Past Year -53,364,000
Net Income Prior Year -16,782,000
Quarterly Revenue Growth YOY -39.30%
5-Year Revenue Growth -7.27%
Operating Margin Twelve Trailing Months -256.00%

Balance Sheet

Total Cash Most Recent Quarter 88,000
Total Cash Past Year 678,000
Total Cash Prior Year 1,609,000
Net Cash Position Most Recent Quarter -1,746,000
Net Cash Position Past Year -10,974,000
Long Term Debt Past Year 11,652,000
Long Term Debt Prior Year 10,258,000
Total Debt Most Recent Quarter 1,834,000
Equity to Debt Ratio Past Year 0.39
Equity to Debt Ratio Most Recent Quarter 0.89
Total Stockholder Equity Past Year 7,353,000
Total Stockholder Equity Prior Year 49,383,000
Total Stockholder Equity Most Recent Quarter 15,118,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -16,002,000
Free Cash Flow Per Share Twelve Trailing Months -0.39
Free Cash Flow Past Year -18,444,000
Free Cash Flow Prior Year -14,503,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.01
MACD Signal 0.00
20-Day Bollinger Lower Band 0.25
20-Day Bollinger Middle Band 0.36
20-Day Bollinger Upper Band 0.47
Beta -0.42
RSI 63.44
50-Day SMA 1.10
150-Day SMA 5.00
200-Day SMA 5.64

System

Modified 7/11/2025 8:39:59 AM EST